healthcare · stock-sale · committee-conflict

Ways and Means Health Subcommittee Member Kevin Hern Sells UnitedHealth Group Stock

Rep. Kevin Hern sold up to $50,000 of the healthcare giant just days before federal auditors flagged Medicare Advantage overpayments.

2026-09-29 — Kevin Hern · UNH

Key facts

• Rep. Kevin Hern sold between $15,001 and $50,000 of UnitedHealth Group stock on September 10, 2026.
• Hern sits on the House Ways and Means Subcommittee on Health, which oversees private health insurance and Medicare Advantage.
• The sale occurred seven days before the publication of federal audits alleging $47 million in Medicare Advantage overpayments by UnitedHealthcare.
• The trade was executed on the same day as seven other stock sales and two exchanges, pointing to a broader portfolio rebalancing.

Rep. Kevin Hern (R-Okla.) recently trimmed his position in healthcare giant UnitedHealth Group (UNH), selling between $15,001 and $50,000 of stock on September 10, 2026. The transaction, which Hern disclosed 15 days later on September 25, has drawn attention due to his legislative portfolio. Hern sits on the House Committee on Ways and Means Subcommittee on Health, which holds direct legislative and oversight jurisdiction over Medicare Advantage payment structures, private health insurance, and federal healthcare funding mechanisms.

The timing of the transaction is notable. Exactly one week after Hern's sale, on September 17, news reports detailed Department of Health and Human Services Office of Inspector General (HHS OIG) audits alleging that UnitedHealthcare entities had received roughly $47 million in Medicare Advantage diagnosis code overpayments. While the audit's publication represents a negative regulatory catalyst, it occurred post-trade, and the financial impact is negligible relative to UnitedHealth's scale.

The transaction also occurred shortly after UnitedHealth Group filed an 8-K on September 8 describing its participation in an industry healthcare conference, and weeks after Optum CEO Patrick Conway sold a portion of his own shares in the open market. Earlier in the summer, the company had reported its Q2 earnings on July 16.

Whether the trade represents an informational edge or routine portfolio management remains an open question. On the exact same day, Hern executed at least seven other sales across highly diverse, unrelated equities—including Home Depot, Novo Nordisk, and Eaton—alongside two large Oneok (OKE) exchanges. This cluster of activity suggests the UnitedHealth transaction was likely part of a broader, programmatic portfolio rebalancing rather than a targeted play. Our analysis scored the trade 49 out of 100.

Members of Congress are required by the STOCK Act to disclose trades within 45 days, and disclosed amounts are reported in ranges. Hern is a highly active trader, having logged nearly 800 trades since late 2018 across a highly diversified portfolio.

For a lawmaker overseeing the nation's health insurance rules, even routine financial housekeeping can look like a policy prescription.

Sources

1. UnitedHealth Group Q2 2026 Earnings 8-K — SEC EDGAR
2. Optum CEO Patrick Conway Form 4 Insider Sale — SEC EDGAR
3. UnitedHealth Group Wells Fargo Conference 8-K — SEC EDGAR
4. HHS OIG Audit Humana UnitedHealthcare Medicare Advantage Upcoding Overpayments — Healthcare Dive

All stories · Kevin Hern · UNH